Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
You could win a cash prize of up to £25,000 when you play the Breakthrough T1D lottery. As well as the chance to win great prizes, you’ll also help fund our research to find a cure for type 1 diabetes.
Invite your friends, family, colleagues or clients to an exceptional black-tie event in the heart of London. Every ticket, every bid, every moment helps us move closer to a cure.
Our ambitious new roadmap is aimed at driving significant advancements in type 1 diabetes research, treatment, and care.
Join the type 1 diabetes community and come together, raising awareness and vital funds for T1D.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
JDRF has now rebranded to Breakthrough T1D. Our name has changed, our mission has not.
Home > News & events > News > JDRF-funded researchers develop a genetic test to detect diabetic kidney disease early
Researchers have identified genes that predict the development and progression of diabetic kidney disease, giving us the potential to limit how many people with type 1 experience kidney failure and need invasive treatments such as dialysis.
The researchers, led by JDRF-funded Professor Sam El-Osta, used genetics data from four countries to develop a predictive test for diabetic kidney disease. Team leader of the human epigenetics group, Professor Sam El-Osta from the Department of Diabetes at Monash University, Australia, said: “Our discoveries will influence how we screen people for diabetic kidney disease and improve risk identification, disease prediction and diagnosis.”
Diabetic kidney disease (DKD) is also called diabetic nephropathy because kidneys are made up of lots of small units called nephrons, which filter blood to remove waste. Diabetes can cause damage to the small blood vessels in the kidneys, which in turn damages the nephrons. DKD affects almost a third of people with type 1 diabetes, so it’s an important topic for type 1 researchers.
Clinicians currently use blood and urine tests as well as samples of a person’s kidneys to assess for DKD. But these measures are only sensitive enough to detect DKD once there is already quite a lot of damage. Dr Ishant Khurana, who was part of the international research team in this study, said: “The early stages of diabetic kidney disease are typically without symptoms. We have developed a reliable method that improves predictive risk and diagnostic accuracy.”
Before now, genetic risk studies for DKD have only looked at the genes themselves, but Professor El-Osta’s team studied small tags attached to the genes. These tags are called DNA methylation and can turn genes on or off. So, even if a person has certain genes, these tags can switch them off, so the genes stop working.
The international research team looked at the DNA methylation tags of people with type 1 diabetes from Finland, Denmark, Hong Kong, and Thailand. They found common patterns in the genetics of people from all these countries. People with type 1 diabetes who had fewer DNA tags (less DNA methylation) had a higher risk of developing DKD.
Using this pattern shown in the research data, the researchers developed a genetic test that shows who is most likely to develop DKD. Professor El-Osta said: “This type of genetic testing is going to be the new standard for early detection and DKD care. Our new blood-based test can be readily available and used in remote areas with the added advantage of being more stable than methods measuring other biological parameters.”
This exciting breakthrough means that people with type 1 will be able to tell earlier whether they are at high risk of developing DKD. This will give people more time to learn about DKD and take precautions to slow the progression of their kidney damage. The researchers hope this early detection will help limit how many people with type 1 experience kidney failure and need invasive treatments such as dialysis.
The full study is detailed in a scientific paper published in a journal called Journal of Clinical Investigation. Read the full research study on the early detection of diabetic kidney disease.
In a landmark moment, the MHRA has licensed the use of teplizumab in the UK, the first-ever disease-modifying therapy for T1D.
In the study, nearly two thirds of young people diagnosed with type 1 diabetes (T1D) did not have the typical identifiers of the condition.
A recent study has shown that a treatment currently used for type 2 diabetes could be used to help prevent kidney damage in young adults with type 1.
New data from Sana Biotechnology, in collaboration with Uppsala University Hospital in Sweden, shows that six months post-transplant, one person with type 1 diabetes (T1D) is successfully producing insulin and does not require immunosuppression.
Don’t miss out on the latest research, inspiring stories, tech news, upcoming events, and handy information on living well with type 1. Join us now and receive it all straight to your inbox.
It’s thanks to your dedication that we have funded great progress in type 1 cure, treatment and prevention research. Help us to continue our vital research.
